Dr Reddy’s in 'timely divestiture' of neurology products for $110m 18-Jun-2019 By Ben Hargreaves Dr Reddy’s enters asset purchase agreement with Upsher-Smith to sell rights for its neurology products, Zembrace and Tosymra.